Patient Access
Dr. Andrew Mellin, VP and CMIO at Surescripts, and Dr. Nele Jessel, CMO at athenahealth, discuss integrating real-time prescription benefits into provider workflows to remove sticker shock and improving adherence and the benefits to value-based care.
 
 
        
        
          
          HIMSS24
          
      
                    
            
  According to Will Cantrell, InteliChart's director of product solutions, the company’s unified platform makes it easy for patients to schedule appointments and message clinicians without downloading an app or logging in to an account.
 
        
        
          The acquisition will allow the fertility and family-building company to provide its services in more than 100 countries and in over 225 languages.
        
        
          At AWE2024 in Long Beach, California, Fundamental VR announced it has incorporated AI into its surgical training platform, and HouseCall VR relayed it has signed an agreement with the University of Georgia College of Pharmacy.
        
        
          
          HIMSS24
          
      
                    
            
  Jesus Diaz, director, nursing informatics at Memorial Healthcare System, tells the story of a mother who used the health system's mobile app to monitor her premature twins' NICU progress. It reduced her anxiety when she couldn't be there.
 
        
        
          Patients in Switzerland will have access to Mika Health's psychological support offerings in conjunction with pharmaceutical therapy.
        
        
          The company is now an in-network provider with numerous insurers and commercial and Medicare Advantage plans, expanding its reach to all 50 states.
        
        
          Aaron Gani, CEO and founder of RealizedCare, discusses the evolution of digital therapeutics, the FDA’s place in advancing them, keeping up with evolving technology, and the benefits of DTx modalities for the pharmaceutical industry.
 
        
        
          The telemedicine company's clinical president and its founder and CEO allegedly participated in a scheme to profit from providing easy access to Adderall for no valid medical purpose.
        
        
          Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the definition of a digital therapeutic, companies in the DTx space, why the organization held its recent summit in D.C. and the status of the Prescription Digital Therapeutics Act.